The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Long term hormone therapy for perimenopausal and postmenopausal women
Open accessAbstract
BACKGROUND: Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women. This is an updated version of a Cochrane review first published in 2005. OBJECTIVES: To assess effects of long-term HT (at least 1 year's duration) on mortality, cardiovascular outcomes, cancer, gallbladder disease, fracture and cognition in perimenopausal and postmenopausal women during and after cessation of treatment. SEARCH METHODS: We searched the following databases to September 2016: Cochrane Gynaecology and Fertility Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase and PsycINFO. We searched the registers of ongoing trials and reference lists provided in previous studies and systematic reviews. SELECTION CRITERIA: We included randomised double-blinded studies of HT versus placebo, taken for at least 1 year by perimenopausal or postmenopausal women. HT included oestrogens, with or without progestogens, via the oral, transdermal, subcutaneous or intranasal route. DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies, assessed risk of bias and extracted data. We calculated risk ratios (RRs) for dichotomous data and mean differences (MDs) for continuous data, along with 95% confidence intervals (CIs). We assessed the quality of the evidence by using GRADE methods. MAIN RESULTS: We included 22 studies involving 43,637 women. We derived nearly 70% of the data from two well-conducted studies (HERS 1998; WHI 1998). Most participants were postmenopausal American women with at least some degree of comorbidity, and mean participant age in most studies was over 60 years. None of the studies focused on perimenopausal women.In relatively healthy postmenopausal women (i.e. generally fit, without overt disease), combined continuous HT increased the risk of a coronary event (after 1 year's use: from 2 per 1000 to between 3 and 7 per 1000), venous thromboembolism (after 1 year's use: from 2 per 1000 to between 4 and 11 per 1000), stroke (after 3 years' use: from 6 per 1000 to between 6 and 12 per 1000), breast cancer (after 5.6 years' use: from 19 per 1000 to between 20 and 30 per 1000), gallbladder disease (after 5.6 years' use: from 27 per 1000 to between 38 and 60 per 1000) and death from lung cancer (after 5.6 years' use plus 2.4 years' additional follow-up: from 5 per 1000 to between 6 and 13 per 1000).Oestrogen-only HT increased the risk of venous thromboembolism (after 1 to 2 years' use: from 2 per 1000 to 2 to 10 per 1000; after 7 years' use: from 16 per 1000 to 16 to 28 per 1000), stroke (after 7 years' use: from 24 per 1000 to between 25 and 40 per 1000) and gallbladder disease (after 7 years' use: from 27 per 1000 to between 38 and 60 per 1000) but reduced the risk of breast cancer (after 7 years' use: from 25 per 1000 to between 15 and 25 per 1000) and clinical fracture (after 7 years' use: from 141 per 1000 to between 92 and 113 per 1000) and did not increase the risk of coronary events at any follow-up time.Women over 65 years of age who were relatively healthy and taking continuous combined HT showed an increase in the incidence of dementia (after 4 years' use: from 9 per 1000 to 11 to 30 per 1000). Among women with cardiovascular disease, use of combined continuous HT significantly increased the risk of venous thromboembolism (at 1 year's use: from 3 per 1000 to between 3 and 29 per 1000). Women taking HT had a significantly decreased incidence of fracture with long-term use.Risk of fracture was the only outcome for which strong evidence showed clinical benefit derived from HT (after 5.6 years' use of combined HT: from 111 per 1000 to between 79 and 96 per 1000; after 7.1 years' use of oestrogen-only HT: from 141 per 1000 to between 92 and 113 per 1000). Researchers found no strong evidence that HT has a clinically meaningful impact on the incidence of colorectal cancer.One trial analysed subgroups of 2839 relatively healthy women 50 to 59 years of age who were taking combined continuous HT and 1637 who were taking oestrogen-only HT versus similar-sized placebo groups. The only significantly increased risk reported was for venous thromboembolism in women taking combined continuous HT: Their absolute risk remained low, at less than 1/500. However, other differences in risk cannot be excluded, as this study was not designed to have the power to detect differences between groups of women within 10 years of menopause.For most studies, risk of bias was low in most domains. The overall quality of evidence for the main comparisons was moderate. The main limitation in the quality of evidence was that only about 30% of women were 50 to 59 years old at baseline, which is the age at which women are most likely to consider HT for vasomotor symptoms. AUTHORS' CONCLUSIONS: Women with intolerable menopausal symptoms may wish to weigh the be
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Kurman, R. J., Kaminski, P. F., & Norris, H. J. (1985) · Cancer · doi:10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x · Cited by 1,252
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,221
Wassertheil-Smoller, S., Hendrix, S., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J. D., Black, H., Rossouw, J. E., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2673 · Cited by 1,159
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 991
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
Lindsay, R., Aitken, J. M., Anderson, L. B., Hart, D. M., Macdonald, E. B., & Clarke, A. C. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92217-0 · Cited by 952
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 864
OUTCOME FOR INFANTS OF VERY LOW BIRTHWEIGHT: SURVEY OF WORLD LITERATURE
STEWART, A. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92198-x · Cited by 830
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
Espeland, M. A. (2004) · JAMA · doi:10.1001/jama.291.24.2959 · Cited by 795
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
(2012) · Menopause · doi:10.1097/gme.0b013e31824b970a · Cited by 785
Vascular effects of early versus late postmenopausal treatment with estradiol
Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505241 · Cited by 779
Schierbeck, L. L., Rejnmark, L., Tofteng, C. L., Stilgren, L., Eiken, P., Mosekilde, L., Kober, L., & Jensen, J.-E. B. (2012) · BMJ · doi:10.1136/bmj.e6409 · Cited by 747
The women's health initiative recruitment methods and results
Hays, J., Hunt, J. R., Hubbell, F. A., Anderson, G. L., Limacher, M., Allen, C., & Rossouw, J. E. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00042-5 · Cited by 742
Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & for the Heart and Estrogen/progestin Replacement Study Research Group (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00002 · Cited by 715
Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C.-R., Liu, C.-H., Azen, S. P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 687
Effects of estrogen plus progestin on health-related quality of life
Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., Aragaki, A. K., Shumaker, S. A., Brzyski, R. G., LaCroix, A. Z., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030311 · Cited by 686
Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women
Chlebowski, R. T., Wactawski-Wende, J., Ritenbaugh, C., Hubbell, F. A., Ascensao, J., Rodabough, R. J., Rosenberg, C. A., Taylor, V. M., Harris, R., Chen, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032071 · Cited by 669
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups
Avis, N. E., Stellato, R., Crawford, S., Bromberger, J., Ganz, P., Cain, V., & Kagawa-Singer, M. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00147-7 · Cited by 643
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00005 · Cited by 633
Estrogen plus progestin and risk of venous thrombosis
Cushman, M. (2004) · JAMA · doi:10.1001/jama.292.13.1573 · Cited by 632
Hormone therapy for preventing cardiovascular disease in post-menopausal women
Boardman, H. M., Hartley, L., Eisinga, A., Main, C., Roqué i Figuls, M., Bonfill Cosp, X., Gabriel Sanchez, R., & Knight, B. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002229.pub4 · Cited by 612
Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative
Hsia, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.357 · Cited by 610
Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer
Lacey, Jr. (2002) · JAMA · doi:10.1001/jama.288.3.334 · Cited by 606
IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis
Cranney, A., Guyatt, G., Griffith, L., Wells, G., Tugwell, P., Rosen, C., The Osteoporosis Methodology Group, & The Osteoporosis Research Advisory Group (2002) · Endocrine Reviews · doi:10.1210/er.2001-9002 · Cited by 604
Local oestrogen for vaginal atrophy in postmenopausal women
Lethaby, A., Ayeleke, R. O., & Roberts, H. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub3 · Cited by 601
Self-citationHulley, S., Furberg, C., Barrett-Connor, E., Cauley, J., Grady, D., Haskell, W., Knopp, R., Lowery, M., Satterfield, S., Schrott, H., et al. (2002) · JAMA · doi:10.1001/jama.288.1.58 · Cited by 595
Vascular Actions of Estrogens: Functional Implications
Miller, V. M., & Duckles, S. P. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.08002 · Cited by 593
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
Barrett-Connor, E., & Grady, D. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.55 · Cited by 590
Waters, D. D., Alderman, E. L., Hsia, J., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P., Tardif, J. C., Higginson, L., et al. (2002) · JAMA · doi:10.1001/jama.288.19.2432 · Cited by 577
Hulley, S. B. (2002) · JAMA · Cited by 577
Stefanick, M. L., Anderson, G. L., Margolis, K. L., Hendrix, S. L., Rodabough, R. J., Paskett, E. D., Lane, D. S., Hubbell, F. A., Assaf, A. R., Sarto, G. E., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1647 · Cited by 571
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Chlebowski, R. T., Anderson, G. L., Gass, M., Lane, D. S., Aragaki, A. K., Kuller, L. H., Manson, J. E., Stefanick, M. L., Ockene, J., Sarto, G. E., et al. (2010) · JAMA · doi:10.1001/jama.2010.1500 · Cited by 567
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978.pub2 · Cited by 543
LaCroix, A. Z. (2011) · JAMA · doi:10.1001/jama.2011.382 · Cited by 538
Holmberg, L., & Anderson, H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15493-7 · Cited by 533
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001833 · Cited by 490
Evidence from randomised trials on the long-term effects of hormone replacement therapy
Beral, V., Banks, E., & Reeves, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11032-4 · Cited by 487
Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women
Chlebowski, R. T., Kuller, L. H., Prentice, R. L., Stefanick, M. L., Manson, J. E., Gass, M., Aragaki, A. K., Ockene, J. K., Lane, D. S., Sarto, G. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807684 · Cited by 472
Greendale, G. A., Lee, N. P., & Arriola, E. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05352-5 · Cited by 467
NACHTIGALL, L. E., NACHTIGALL, R. H., NACHTIGALL, R. D., & BECKMAN, M. E. (1979) · Obstetrics & Gynecology · doi:10.1097/00006250-197907000-00017 · Cited by 446
The Post-Graduate Medical Journal
H., H. B. (1928) · Journal of The Royal Naval Medical Service · doi:10.1136/jrnms-14-70a · Cited by 442
Estrogen replacement therapy, atherosclerosis, and vascular function
Mikkola, T. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00466-7 · Cited by 420
Postmenopausal Hormone Therapy and Change in Mammographic Density
Greendale, G. A., Reboussin, B. A., Slone, S., Wasilauskas, C., Pike, M. C., & Ursin, G. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.30 · Cited by 419
Simon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E., & Hulley, S. B. (2001) · Circulation · doi:10.1161/01.cir.103.5.638 · Cited by 403
Hormone replacement therapy: Fortnightly review
Barrett-Connor, E. (1998) · BMJ · doi:10.1136/bmj.317.7156.457 · Cited by 403
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Heiss, G. (2008) · JAMA · doi:10.1001/jama.299.9.1036 · Cited by 396
Oestrogen therapy for urinary incontinence in post-menopausal women
Cody, J. D., Jacobs, M. L., Richardson, K., Moehrer, B., & Hextall, A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001405.pub3 · Cited by 391
Age of menopause and impact of climacteric symptoms by geographical region
Palacios, S., Henderson, V. W., Siseles, N., Tan, D., & Villaseca, P. (2010) · Climacteric · doi:10.3109/13697137.2010.507886 · Cited by 386
Jensen, J., Christiansen, C., & Rødbro, P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131602 · Cited by 382
Wells, G., Tugwell, P., Shea, B., Guyatt, G., Peterson, J., Zytaruk, N., Robinson, V., Henry, D., O’Connell, D., Cranney, A., et al. (2002) · Endocrine Reviews · doi:10.1210/er.2001-5002 · Cited by 372
Anderson, G. L., Chlebowski, R. T., Aragaki, A. K., Kuller, L. H., Manson, J. E., Gass, M., Bluhm, E., Connelly, S., Hubbell, F. A., Lane, D., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70075-x · Cited by 364
Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative
Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., Trevisan, M., Aragaki, A., Baird, A. E., Bray, P. F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594077 · Cited by 359
Local oestrogen for vaginal atrophy in postmenopausal women
Suckling, J. A., Kennedy, R., Lethaby, A., & Roberts, H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub2 · Cited by 359
Self-citationHarman, S. M., Black, D. M., Naftolin, F., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hopkins, P. N., Lobo, R. A., Manson, J. E., Merriam, G. R., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0353 · Cited by 344
Increased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors
Holmberg, L., Iversen, O.-E., Rudenstam, C. M., Hammar, M., Kumpulainen, E., Jaskiewicz, J., Jassem, J., Dobaczewska, D., Fjosne, H. E., Peralta, O., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn058 · Cited by 344
Bhattacharya, D., Aldus, C. F., Barton, G., Bond, C. M., Boonyaprapa, S., Charles, I. S., Fleetcroft, R., Holland, R., Jerosch‐Herold, C., Salter, C., et al. (2016) · Cited by 339
(2002) · The Lancet · doi:10.1016/s0140-6736(02)12001-0 · Cited by 333
Chlebowski, R. T., Schwartz, A. G., Wakelee, H., Anderson, G. L., Stefanick, M. L., Manson, J. E., Rodabough, R. J., Chien, J. W., Wactawski-Wende, J., Gass, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61526-9 · Cited by 322
The Women’s Health Initiative Memory Study (WHIMS)
Shumaker, S. A., Reboussin, B. A., Espeland, M. A., Rapp, S. R., McBee, W. L., Dailey, M., Bowen, D., Terrell, T., & Jones, B. N. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00038-5 · Cited by 321
Barnabei, V. M., Cochrane, B. B., Aragaki, A. K., Nygaard, I., Williams, R. S., McGovern, P. G., Young, R. L., Wells, E. C., OʼSullivan, M. J., Chen, B., et al. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158120.47542.18 · Cited by 320
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick, S. M., Maki, P. M., Rapp, S. R., Espeland, M. A., Brunner, R., Coker, L. H., Granek, I. A., Hogan, P., Ockene, J. K., & Shumaker, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2097 · Cited by 310
Effect of Estrogen Therapy on Gallbladder Disease
Cirillo, D. J. (2005) · JAMA · doi:10.1001/jama.293.3.330 · Cited by 304
Hlatky, M. A., Boothroyd, D., Vittinghoff, E., Sharp, P., Whooley, M. A., & for the HERS Research Group (2002) · JAMA · doi:10.1001/jama.287.5.591 · Cited by 303
Mortality associated with hormone replacement therapy in younger and older women: A meta-analysis
Salpeter, S. R., Walsh, J. M. E., Greyber, E., Ormiston, T. M., & Salpeter, E. E. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30281.x · Cited by 292
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Beral, V., Reeves, G., Bull, D., Green, J., & Collaborators, F. T. M. W. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq527 · Cited by 292
Clarke, S. (2002) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(02)01544-6 · Cited by 267
Høibraaten, E., Qvigstad, E., Arnesen, H., Larsen, S. U., Wickström, E., & Sandset, P. (2000) · PubMed · Cited by 266
Heart and Estrogen/progestin Replacement Study (HERS)
Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00010-5 · Cited by 260
Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy
Aitken, J. M., Hart, D. M., & Lindsay, R. (1973) · BMJ · doi:10.1136/bmj.3.5879.515 · Cited by 259
Vickers, M. R., MacLennan, A. H., Lawton, B., Ford, D., Martin, J., Meredith, S. K., DeStavola, B. L., Rose, S., Dowell, A., Wilkes, H. C., et al. (2007) · BMJ · doi:10.1136/bmj.39266.425069.ad · Cited by 254
Hemminki, E., & McPherson, K. (1997) · BMJ · doi:10.1136/bmj.315.7101.149 · Cited by 253
Sartore-Bianchi, A., Ardini, E., Bosotti, R., Amatu, A., Valtorta, E., Somaschini, A., Raddrizzani, L., Palmeri, L., Banfi, P., Bonazzina, E., et al. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv306 · Cited by 245
Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis
Henderson, V. W., St. John, J. A., Hodis, H. N., McCleary, C. A., Stanczyk, F. Z., Shoupe, D., Kono, N., Dustin, L., Allayee, H., & Mack, W. J. (2016) · Neurology · doi:10.1212/wnl.0000000000002980 · Cited by 242
Angerer, P., Störk, S., Kothny, W., Schmitt, P., & von Schacky, C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.2.262 · Cited by 240
Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Pettinger, M., Yood, R. A., Watts, N. B., Robbins, J. A., Lewis, C. E., Beresford, S. A., Ko, M. G., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060312 · Cited by 239
Anderson, G. L., Chlebowski, R. T., Rossouw, J. E., Rodabough, R. J., McTiernan, A., Margolis, K. L., Aggerwal, A., Curb, J. D., Hendrix, S. L., Hubbell, F. A., et al. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.05.004 · Cited by 239
Barakat, R. R., Bundy, B. N., Spirtos, N. M., Bell, J., & Mannel, R. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8464 · Cited by 238
Association between hormone replacement therapy and subsequent stroke: a meta-analysis
Bath, P. M. W., & Gray, L. J. (2005) · BMJ · doi:10.1136/bmj.38331.655347.8f · Cited by 236
Herrington, D. M., Vittinghoff, E., Lin, F., Fong, J., Harris, F., Hunninghake, D., Bittner, V., Schrott, H. G., Blumenthal, R. S., & Levy, R. (2002) · Circulation · doi:10.1161/01.cir.0000019406.74017.b2 · Cited by 235
Komulainen, M. H., Kröger, H., Tuppurainen, M. T., Heikkinen, A.-M., Alhava, E., Honkanen, R., & Saarikoski, S. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00085-1 · Cited by 235
Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice, R. L., Manson, J. E., Langer, R. D., Anderson, G. L., Pettinger, M., Jackson, R. D., Johnson, K. C., Kuller, L. H., Lane, D. S., Wactawski-Wende, J., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp115 · Cited by 234
Stefanick, M. L., Cochrane, B. B., Hsia, J., Barad, D. H., Liu, J. H., & Johnson, S. R. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00045-0 · Cited by 232
Bowen, A., Hesketh, A., Patchick, E., Young, A., Davies, L., Vail, A., Long, A. F., Watkins, C., Wilkinson, M., Pearl, G., et al. (2012) · BMJ · doi:10.1136/bmj.e4407 · Cited by 229
Hormone Replacement Therapy and the Risk of Invasive Epithelial Ovarian Cancer in Swedish Women
Riman, T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.497 · Cited by 228
Genant, H. K. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440430091011 · Cited by 228
Espeland, M. A. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.7727 · Cited by 226
Grady, D., Yaffe, K., Kristof, M., Lin, F., Richards, C., & Barrett-Connor, E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01270-6 · Cited by 222
Hot flashes: phenomenology, quality of life, and search for treatment options
Kronenberg, F. (1994) · Experimental Gerontology · doi:10.1016/0531-5565(94)90012-4 · Cited by 217
Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus
Curb, J. D., Prentice, R. L., Bray, P. F., Langer, R. D., Van Horn, L., Barnabei, V. M., Bloch, M. J., Cyr, M. G., Gass, M., Lepine, L., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.772 · Cited by 217
Hormone replacement therapy for cognitive function in postmenopausal women
Lethaby, A., Hogervorst, E., Richards, M., Yesufu, A., & Yaffe, K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003122.pub2 · Cited by 214
Self-citationChlebowski, R. T., Rohan, T. E., Manson, J. E., Aragaki, A. K., Kaunitz, A., Stefanick, M. L., Simon, M. S., Johnson, K. C., Wactawski-Wende, J., O’Sullivan, M. J., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0494 · Cited by 211
Welton, A. J., Vickers, M. R., Kim, J., Ford, D., Lawton, B. A., MacLennan, A. H., Meredith, S. K., Martin, J., Meade, T. W., & for the WISDOM team (2008) · BMJ · doi:10.1136/bmj.a1190 · Cited by 205
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
Furness, S., Roberts, H., Marjoribanks, J., Lethaby, A., Hickey, M., & Farquhar, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000402.pub3 · Cited by 194
Self-citationSaitta, A., Altavilla, D., Cucinotta, D., Morabito, N., Frisina, N., Corrado, F., D’Anna, R., Lasco, A., Squadrito, G., Gaudio, A., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095565 · Cited by 188
Qvigstad, E., Arnesen, H., Larsen, S., Wickstrøm, E., Sandset, P., & Høibraaten, E. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614156 · Cited by 184
Hodis, H. N., Mack, W. J., Shoupe, D., Azen, S. P., Stanczyk, F. Z., Hwang-Levine, J., Budoff, M. J., & Henderson, V. W. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000343 · Cited by 168
Hormone replacement therapy to maintain cognitive function in women with dementia
Hogervorst, E., Yaffe, K. S., Richards, M., & Huppert, F. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003799.pub2 · Cited by 163
Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial
Guidozzi, F., & Daponte, A. I. (1999) · Cancer · Cited by 160
de Valk-de Roo, G. W., Stehouwer, C. D. A., Meijer, P., Mijatovic, V., Kluft, C., Kenemans, P., Cohen, F., Watts, S., & Netelenbos, C. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.2993 · Cited by 158
The WHI Estrogen-Alone Trial—Do Things Look Any Better?
Hulley, S. B. (2004) · JAMA · doi:10.1001/jama.291.14.1769 · Cited by 156
Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?
Cotter, G., Shemesh, E., Zehavi, M., Dinur, I., Rudnick, A., Milo, O., Vered, Z., Krakover, R., Kaluski, E., & Kornberg, A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.07.011 · Cited by 153
The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer
Jordan, V. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0448 · Cited by 145
Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reslan, O. M., & Khalil, R. A. (2012) · Reviews on Recent Clinical Trials · doi:10.2174/157488712799363253 · Cited by 143
Eeles, R. A., Morden, J. P., Gore, M. E., Mansi, J., Glees, J. P., Wenczl, M., Williams, C. M., Kitchener, H. C., Osborne, R. H., Guthrie, D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.60.9719 · Cited by 140
Update in Hormone Therapy Use in Menopause
Taylor, H. S., & Manson, J. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0536 · Cited by 137
Kongnyuy, E. J., Norman, R. J., Flight, I. H. K., & REES, M. C. P. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001018 · Cited by 135
Hot flushes during the menopause transition: a longitudinal study in Australian-born women
Guthrie, J. R., Dennerstein, L., Taffe, J. R., Lehert, P., & Burger, H. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000155200.80687.be · Cited by 135
Hormone therapy for sexual function in perimenopausal and postmenopausal women
Nastri, C. O., Lara, L. A. D. S., Ferriani, R. A., Rosa-e-Silva, A. C. J., Figueiredo, J. B., & Martins, W. P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009672.pub2 · Cited by 130
The postmenopausal estrogen/progestin interventions study: primary outcomes in adherent women
Barrett-Connor, E. L., Slone, S. A., Greendale, G. A., Kritz‐Silverstein, D. C., Espeland, M. A., Johnson, S. R., Waclawiw, M. A., & Fineberg, S. E. (1997) · Maturitas · doi:10.1016/s0378-5122(97)00041-8 · Cited by 130
Women's Health Initiative: Why now? What is it? What's new?
Matthews, K. A., Shumaker, S. A., Bowen, D. J., Langer, R. D., Hunt, J. R., Kaplan, R. M., Klesges, R. C., & Ritenbaugh, C. (1997) · American Psychologist · doi:10.1037/0003-066x.52.2.101 · Cited by 128
Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women
Ismail, S. I. M. F., Bain, C., & Hagen, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007063.pub2 · Cited by 127
Chlebowski, R. T., Anderson, G. L., Manson, J. E., Schwartz, A. G., Wakelee, H. A., Gass, M. L. S., Rodabough, R. J., Johnson, K., Wactawski‐Wende, J., Kotchen, J. M., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq285 · Cited by 125
Toh, S., Hernández–Díaz, S., Logan, R. W., Rossouw, J. E., & Hernán, M. Á. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-4-201002160-00005 · Cited by 123
Brunner, R. L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1976 · Cited by 122
Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis
Greiser, C. M., Greiser, E. M., & Dören, M. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm012 · Cited by 122
Banks, E., REEVES, G. K., Beral, V., Balkwill, A., Liu, B. C., Roddam, A., & Collaborators, F. T. M. W. S. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000181 · Cited by 122
Effects of Ultra–Low-Dose Transdermal Estradiol on Cognition and Health-Related Quality of Life
Yaffe, K. S., Vittinghoff, E., Ensrud, K. E., Johnson, K., Diem, S. J., Hanes, V., & Grady, D. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.945 · Cited by 118
Postmenopausal Hormones — Therapy for Symptoms Only
Grady, D. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030038 · Cited by 116
Resnick, S. M., Cokerb, L. H., Maki, P. M., Rapp, S. R., Espeland, M. A., & Shumakerb, S. A. (2004) · Clinical Trials · doi:10.1191/1740774504cn040oa · Cited by 113
Estrogen Plus Progestin and Colorectal Cancer Incidence and Mortality
Simon, M. S., Chlebowski, R. T., Wactawski‐Wende, J., Johnson, K., Muskovitz, A. A., Kato, I., Young, A., Hubbell, F. A., & Prentice, R. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7732 · Cited by 111
Qvigstad, E., Andersen, T. O., Mowinckel, M.-C., Sandset, P. M., & Høibraaten, E. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615717 · Cited by 109
Chlebowski, R. T., Anderson, G. L., Sarto, G. E., Haque, R., Runowicz, C. D., Aragaki, A. K., Thomson, C. A., Howard, B. V., Wactawski‐Wende, J., Chen, C., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv350 · Cited by 109
Resnick, S. M., Espeland, M. A., An, Y., Maki, P. M., Coker, L. H., Jackson, R. D., Stefanick, M. L., Wallace, R. B., Rapp, S. R., & for the Women’s Health Initiative Study of Cognitive Aging Investigators (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1340 · Cited by 108
Ritenbaugh, C., Stanford, J. L., Wu, L., Shikany, J. M., Schoen, R. E., Stefanick, M. L., Taylor, V., Garland, C. F., Frank, G. C., Lane, D. S., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0385 · Cited by 108
Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy
Chlebowski, R. T. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.123 · Cited by 107
Hormone replacement therapy (HRT)— risks and benefits
Barrett-Connor, E. L., & Stuenkel, C. A. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.423 · Cited by 106
Wharton, W., Baker, L. D., Gleason, C. E., Dowling, N. M., Barnet, J. H., Johnson, S. C., Carlsson, C. M., Craft, S., & Asthana, S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110341 · Cited by 104
Vittinghoff, E., Shlipak, M. G., Varosy, P. D., Furberg, C. D., Ireland, C. C., Khan, S. S., Blumenthal, R. S., Barrett-Connor, E. L., & Hulley, S. B. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00007 · Cited by 103
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.017 · Cited by 101
Simon, J. A., Hunninghake, D. B., Agarwal, S. K., Lin, F., Cauley, J. A., Ireland, C. C., & Pickar, J. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00008 · Cited by 98
Walitt, B. T., Pettinger, M. B., Weinstein, A., Katz, J. D., Torner, J. C., Wasko, M. C., Howard, B. V., & Women's Health Initiative Investigators (2008) · Arthritis Care & Research · doi:10.1002/art.23325 · Cited by 98
Høibraaten, E., Mowinckel, M., de Ronde, H., Bertina, R. M., & Sandset, P. M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03111.x · Cited by 96
Hormones and Heart Disease in Women: The Timing Hypothesis
Barrett-Connor, E. L. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm214 · Cited by 92
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women
Sánchez, R. G., Sánchez-Gómez, L. M., Carmona, L., Figuls, M. R. I., & Bonfill, X. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002229.pub2 · Cited by 89
Estrogen alone and joint symptoms in the Women’s Health Initiative randomized trial
Chlebowski, R. T., Cirillo, D. J., Eaton, C. B., Stefanick, M. L., Pettinger, M. B., Carbone, L. D., Johnson, K., Simon, M. S., Woods, N. F., & Wactawski‐Wende, J. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31828392c4 · Cited by 88
Shapiro, S. (2003) · Climacteric · doi:10.1080/713605431 · Cited by 84
Effects of hormone therapy on brain structure
Kantarci, K., Tosakulwong, N., Lesnick, T. G., Zuk, S. M., Gunter, J. L., Gleason, C. E., Wharton, W., Dowling, N. M., Vemuri, P., Senjem, M. L., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002970 · Cited by 84
Rasgon, N., Geist, C. L., Kenna, H. A., Wroolie, T., Williams, K. E., & Silverman, D. H. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089095 · Cited by 83
Byington, R. P., Furberg, C. D., Herrington, D. M., Herd, J. A., Hunninghake, D. B., Lowery, M. H., Riley, W. A., Craven, T. E., Chaput, L. A., Ireland, C. C., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000033514.79653.04 · Cited by 83
Insomnia symptoms and repressive coping in a sample of older Black and White women
Jean‐Louis, G., Magai, C., Consedine, N. S., Pierre-Louis, J., Zizi, F., Casimir, G. J., & Belzie, L. R. (2007) · BMC Women s Health · doi:10.1186/1472-6874-7-1 · Cited by 82
Tierney, M. C., OH, P. I., Moineddin, R., Greenblatt, E. M., Snow, W. G., Fisher, R. H., Iazzetta, J., George‐Hyslop, P. S., & MacLusky, N. J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.02.009 · Cited by 77
Hormone replacement therapy for cognitive function in postmenopausal women
Hogervorst, E., Yaffe, K. S., Richards, M., & Huppert, F. A. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003122 · Cited by 75
The Estrogen Replacement and Atherosclerosis (ERA) Study
Herrington, D. M., Reboussin, D. M., Klein, K. P., Sharp, P. C., Shumaker, S. A., Snyder, T. E., & Geisinger, K. R. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00054-4 · Cited by 74
Banks, E., & Canfell, K. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp113 · Cited by 73
Long-term Effects on Cognitive Trajectories of Postmenopausal Hormone Therapy in Two Age Groups
Espeland, M. A., Rapp, S. R., Manson, J. E., Goveas, J. S., Shumaker, S. A., Hayden, K. M., Weitlauf, J. C., Gaussoin, S. A., Baker, L. D., Padula, C. B., et al. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw156 · Cited by 73
Menopause hormonal therapy in women with systemic lupus erythematosus
Sánchez‐Guerrero, J., González‐Pérez, M., Durand-Carbajal, M., Lara-Reyes, P., Jiménez-Santana, L., Romero‐Díaz, J., & Cravioto, M. D. C. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22855 · Cited by 71
The effect of hormone replacement on physical performance in community-dwelling elderly women
Greenspan, S. L., Resnick, N. M., & Parker, R. A. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.004 · Cited by 71
Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]
Veerus, P., Hovi, S., Fischer, K., Rahu, M., Hakama, M., & Hemminki, E. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.01.012 · Cited by 69
Obel, E. B., Munk‐Jensen, N., Svenstrup, B., Bennett, P., Mičić, S., Henrik-Nielsen, R., Nielsen, S. P., Gydesen, H., & Jensen, B. (1993) · Maturitas · doi:10.1016/0378-5122(93)90129-6 · Cited by 68
Prentice, R. L., Pettinger, M. B., Beresford, S. A. A., Wactawski‐Wende, J., Hubbell, F. A., Stefanick, M. L., & Chlebowski, R. T. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1209 · Cited by 68
Tang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski‐Wende, J., Keiser, E., Thomas, F., Anderson, M. L., Zeitouni, N. C., Larson, J. C., & Stefanick, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr333 · Cited by 68
Effect of 10 Years' Hormone Replacement Therapy on Bone Mineral Content in Postmenopausal Women
Eiken, P. (1996) · Bone · doi:10.1016/s8756-3282(96)00266-9 · Cited by 64
Espeland, M. A., Brinton, R. D., Hugenschmidt, C. E., Manson, J. E., Craft, S., Yaffe, K. S., Weitlauf, J. C., Vaughan, L., Johnson, K., Padula, C. B., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1385 · Cited by 62
Rationale, Design, and Conduct of the PEPI Trial
Espeland, M. A. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00033-y · Cited by 60
Postmenopausal Hormone Use and the Risk of Nephrolithiasis
Maalouf, N. M., Sato, A., Welch, B. J., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.342 · Cited by 58
Vickers, M. R., Martin, J., Meade, T., & the WISDOM study team (2007) · BMC Women s Health · doi:10.1186/1472-6874-7-2 · Cited by 58
Espeland, M. A., Brunner, R. L., Hogan, P. E., Rapp, S. R., Coker, L. H., Legault, C., Granek, I. A., Resnick, S. M., & for the Women's Health Initiative Study of Cognitive Aging Study Group (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02953.x · Cited by 57
Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding
(2000) · Climacteric · doi:10.1080/13697130008500112 · Cited by 55
Karim, R., Mack, W. J., Lobo, R. A., Hwang, J., Liu, C., Liu, C.-H., Sevanian, A., & Hodis, H. N. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000153934.76086.a4 · Cited by 54
Rohan, T. E., Negassa, A., Chlebowski, R. T., Habel, L. A., McTiernan, A., Ginsberg, M. S., Wassertheil-Smoller, S. W., & Page, D. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn075 · Cited by 54
Haines, C. J., Yim, S. F., Chung, T. K. H., Lam, C. W. K., Lau, E. W. C., Ng, M. H. L., Chin, R., & Lee, D. T. S. (2003) · Maturitas · doi:10.1016/s0378-5122(02)00340-7 · Cited by 52
Effect of estrone sulfate on postmenopausal bone loss
Genant, H. K., Baylink, D. J., Gallagher, J. C., Harris, S. T., Steiger, P., & Herber, M. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90313-t · Cited by 52
Pefanco, M. A., Kenny, R. A., Kaplan, R. F., Kuchel, G. A., Walsh, S. J., Kleppinger, A., & Prestwood, K. M. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01085.x · Cited by 51
Hormone replacement therapy to maintain cognitive function in women with dementia
Hogervorst, E., Yaffe, K. S., Richards, M., & Huppert, F. A. (2002) · doi:10.1002/14651858.cd003799 · Cited by 49
Nielsen, T. F., Ravn, P., Bagger, Y. Z., Warming, L., & Christiansen, C. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1535-8 · Cited by 47
Bech, P., Munk‐Jensen, N., Obel, E. B., Ulrich, L. G., Eiken, P., & Nielsen, S. P. (1998) · Psychotherapy and Psychosomatics · doi:10.1159/000012289 · Cited by 46
Estrogen and colorectal cancer incidence and mortality
Lavasani, S. M., Chlebowski, R. T., Prentice, R. L., Kato, I., Wactawski‐Wende, J., Johnson, K., Young, A., Rodabough, R. J., Hubbell, F. A., Mahinbakht, A., et al. (2015) · Cancer · doi:10.1002/cncr.29464 · Cited by 45
Hemminki, E., & McPherson, K. (2000) · The Lancet · doi:10.1016/s0140-6736(99)03432-7 · Cited by 44
The Effect of Ultralow-Dose Transdermal Estradiol on Urinary Incontinence in Postmenopausal Women
Waetjen, L. E., Brown, J. S., Vittinghoff, E., Ensrud, K. E., Pinkerton, J. V., Wallace, R. B., Macer, J. L., & Grady, D. G. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000182576.48290.6d · Cited by 44
Dementia and osteoporosis in a geriatric population: Is there a common link?
Downey, C. L., Young, A., Burton, E., Graham, S. M., MacFarlane, R. J., Tsapakis, E.-M., & Tsiridis, E. E. (2017) · World Journal of Orthopedics · doi:10.5312/wjo.v8.i5.412 · Cited by 43
Mortality associated with hormone replacement therapy in younger and older women
Salpeter, S. R. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.04008.x · Cited by 42
A Practical Guide to Prescribing Hormone Replacement Therapy
McKinney, K. A., & Thompson, W. (1998) · Drugs · doi:10.2165/00003495-199856010-00005 · Cited by 42
Cited by
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Authors/Task Force Members:, Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
Estrogen receptors and human disease
Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,320
Metadata
- Authors
- Farquhar, C., Marjoribanks, J., Lethaby, A., Suckling, J. A., & Lamberts, Q.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2005-07-20
- Volume
- 1
- Issue
- 3
- Pages
- CD004143-CD004143
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W1892432125
- Cited by
- 582
- References
- 246
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.